Bayer Thai Co., Ltd., established in 1962, is a prominent subsidiary of the global Bayer Group, operating as a manufacturer, distributor, and trading company in Thailand. Headquartered in Bangkok, the company maintains a robust industrial presence with a chemical formulation production site in Bangpoo Industrial Estate and multiple specialized facilities across the country, including seed production sites in Phitsanulok, Sakon Nakhon, and Khon Kaen, and research centers in Suphan Buri and Chiang Rai. The company employs between 501 and 1,000 professionals and operates with a significant registered capital of over 1.3 billion Baht.
Bayer Thai focuses on three core life science divisions: Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division specializes in prescription drugs for cardiology, oncology, ophthalmology, and radiology. The Consumer Health segment provides leading over-the-counter (OTC) brands such as Bepanthen, Berocca, Canesten, and Clarityne. In the Crop Science sector, the company is a major provider of crop protection solutions (herbicides, fungicides, and insecticides) and high-quality corn and vegetable seeds for both domestic and export markets.
As an OEM-capable manufacturer, the company adheres to rigorous international standards, holding certifications including ISO 9001, ISO 14001, ISO 45001, and Good Manufacturing Practice (GMP). With an annual production capacity of over 9,000 metric tons at its Bangpoo site, Bayer Thai is committed to innovation and sustainable development in the fields of healthcare and nutrition.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High capacity factoryCan handle large-scale or bulk production orders.
Industry association memberMember of EABC Thailand, AMCHAM Thailand association.
Contact
*****************************
1
*************************************
1
Customers
BAYER
425 shipments
***
No shipments
*********
No shipments
************
No shipments
***************
No shipments
Unlock all 8 customers
Unlock
Certifications
GMP
2
Good Manufacturing Practice
ISO 14001
2
International Organization for Standardization 14001
ISO 9001
2
International Organization for Standardization 9001
ISO 45001
2
International Organization for Standardization 45001
Ask AI about this supplier
Curious about this supplier? Ask AI for a quick overview.
Key export market
🇵🇰 Pakistan🇵🇰 Pakistan
🇵🇭 Philippines🇵🇭 Philippines
🇻🇳 Vietnam🇻🇳 Vietnam
🇮🇳 India🇮🇳 India
🇮🇩 Indonesia🇮🇩 Indonesia
🇲🇽 Mexico🇲🇽 Mexico
🇺🇸 United States🇺🇸 United States
🇧🇪 Belgium🇧🇪 Belgium
🇲🇳 Mongolia🇲🇳 Mongolia
AsiaAsia
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customers
Top 5 customers
This insight is only available in the Pro plan
Top 5 export countries
Reflecting the supplier's export experience in target countries
Top 5 export countries
This insight is only available in the Pro plan
Shipment count distribution
Reflecting the supplier's market business activity
All categories
Loading chart data...
Shipment count distribution
This insight is only available in the Pro plan
Export weight distribution (kg)
Reflecting the supplier's export scale
All categories
Loading chart data...
Export weight distribution (kg)
This insight is only available in the Pro plan
Export weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughs
All categories
Loading chart data...
Export weight trend (kg)
This insight is only available in the Pro plan
CIF trend (USD)
For identifying high-value cooperation periods and single order value changes
Bayer Vietnam Ltd., a subsidiary of the global Bayer Group, is a leading life science company that has been operating in Vietnam since 1994. Headquartered in Bien Hoa, Dong Nai, the company maintains a significant national presence with modern manufacturing facilities in Dong Nai and Binh Duong, supported by branch offices in Hanoi and Ho Chi Minh City. The company employs between 501 and 1,000 professionals and operates under GMP certification, reflecting its commitment to international quality standards.
Food Security
Product Areas
Megatrends Changing the Future
Information for Patients
Khoa học Cây trồng
Megatrends Changing the Future
Chăm sóc Sức khỏe Người tiêu dùng
Medical Counterfeits
Adverse Reactions
Food Security
Megatrends Changing the Future
Medical Counterfeits
Pfizer (Thailand) Limited
🇹🇭 Thailand
1958301-500 peopleService Company/Distributor
Established brand
Industry association member
Multinational enterprise
High-tech enterprise
Shipments
1464
Key customer
MEDSWANA
Key market
🇧🇼 Botswana
Description
Pfizer (Thailand) Limited is a premier biopharmaceutical company and a leading distributor of innovative medicines and vaccines in Thailand. Established in 1958 by Pfizer Inc., the company has grown into one of the country's largest pharmaceutical entities, employing between 301 and 500 dedicated professionals. Based in Bangkok, the company operates as a service provider and distributor, focusing on scientific advancement and the research and development of life-changing treatments. In the 2023 financial year, the company reported a revenue of 4.45 billion THB.
The company's extensive product portfolio specializes in several core therapeutic areas, including oncology, inflammation and immunology, internal medicine, rare diseases, and anti-infectives. Pfizer Thailand is particularly recognized for its leadership in vaccine technology, notably the development and distribution of mRNA COVID-19 vaccines and antiviral treatments. Their offerings encompass a wide range of high-quality, safe, and effective medical supplies designed to address unmet medical needs across all age groups, from pediatrics to geriatric care.
Pfizer Thailand leverages strategic partnerships with local healthcare providers, government agencies, and community entities to expand access to quality healthcare. By utilizing dedicated clinical research teams and biotechnology foundations, the company focuses on delivering breakthrough results and ensuring that innovative medicines are accessible within the Thai healthcare system. Their operations are characterized by a commitment to social responsibility and commercial viability, tailoring strategies to meet the specific needs of Thailand's aging population and evolving healthcare landscape.